Blueskin CRO

I’m excited to be attending the 8th Dermatology Drug Development Summit in Boston this week! 🌎 Starting off tomorrow with pre-conference workshops on the evolving drug development landscape for Hidradenitis Suppurativa, along with the latest news on JAK-inhibitors and safety considerations in dermatology. The rest of the conference agenda is packed with presentations and panel discussions, covering everything from pipeline updates to cutting-edge therapeutic strategies. With dedicated networking breaks, this is as a great opportunity to gain new insights on dermatological therapies and to connect with some of the brightest minds in our field. ⭐️ I’m here to learn and looking forward to exploring potential collaborations that could make a difference for patients with chronic skin conditions. If you’re attending and interested in learning about Blueskin CRO and our expertise in clinical methodology and dermatology clinical research, let’s connect over coffee during one of the networking sessions! ☕🤝 On a lighter note, I had the chance to explore vibrant Boston this afternoon. 🍁🏙️ Walked the historic Freedom Trail, strolled through the Public Garden and the beautiful streets of local Boston, with some obligatory shopping on Newbury Street along the way. Still feeling a bit of jetlag, I’m looking forward to the coming days. #PartofSanosGroup #DDDS2024 #DermatologyDrugDevelopment

#BIO2024 has begun, and I’m thrilled to be part of it with the Blueskin CRO and Sanos Group Team. I am looking forward to exploring new potential partnerships. If you’re also attending and curious to know how Blueskin CRO can help advance clinical drug development programs in the dermatology field, i am happy to meet for introductions in Stockholm. #PartofSanosGroup #Dermatology

Would you like to know more about the common clinical characteristics of major dermatological disorders? Join Global Medical Advisor, Alejandro Castillo Mondragón, and Business Development Manager, Sofie Arpe, at the EADV Congress in Amsterdam, 25-28 September 2024, where they will be happy to discuss Blueskin CRO's accepted abstract: Baseline characteristics of participants from a prospective cohort study in four different dermatological disorders. The abstract describes the baseline characteristics of our ongoing cohort study following patients with Atopic Dermatitis, Alopecia Areata, Psoriasis and Vitiligo in Denmark. In this observational study we are collecting real-life data on disease progression, treatment efficacy and patient outcomes. Reach out to secure a meeting - we look forward to engaging in insightful discussions on the latest research and innovations in dermatology.  See you there! #EADVCongress #ContractResearch #Dermatology #partofSanosGroup

📅 Heading to #BIO2024? So are we! Business Development Manager, Sofie Arpe, will be on ground in San Diego – ready to share insights and build new partnerships. Eager to hear about the capabilities of Blueskin CRO? Don’t miss the chance to connect! Reach out to her on LinkedIn or at soa@sanos.com – there might still be a slot open for you. See you soon! 🙌 #BIO #ContractResearch #Dermatology #ClinicalDevelopment #BlueskinCRO #partofSanosGroup

Counting the days to #BIO2024. ⭐ Next week, I will be travelling to sunny San Diego for this year's BIO International Convention. I am excited to represent Blueskin CRO at this unparalleled partnering convention and looking forward to reconnecting with familiar faces and making new connections. Do not hesitate to reach out for introductions. 🌞 #Dermatology #ClinicalResearch #PartneringConvention #partofSanosGroup

Spend the evening in the lively Tiergarten area of Berlin. Despite a few drops of rain, i am excited to attend the 5th Dermatology Drug Development Summit tomorrow and to have the opportunity to meet with dermatology leaders and discuss how Blueskin CRO can help advance clinical programs as an operational partner. #BlueskinCRO #Dermatology #ClinicalResearch #partofSanosGroup

📅 Meet Blueskin CRO at The 5th Dermatology Drug Development Summit Europe 2024! Blueskin CRO is excited to be part of this pivotal event in Berlin, April 16-18. Sofie Arpe will be representing Blueskin CRO, discussing the latest advancements in dermatology drug development. Join us as we explore emerging needs and advancements in the field. Reach out to Sofie at soa@sanos.com to connect and learn more about our innovative solutions! #DDDS24 #Dermatology #DrugDevelopment #BlueskinCRO #partofSanosGroup

I am delighted to be attending Bio Europe Spring in the vibrant city of Barcelona this week. I am looking forward to meeting familiar faces, interacting with new relations and discussing how Blueskin CRO can help advance your clinical dermatology programs as an operationel partner. Reach out or catch me in the hallway. 🙋🏼♀️ #BioEuropeSpring2024 #ClinicalResearch #Partnering #BlueskinCRO #partofSanosGroup

📅 Save the Date! Blueskin CRO will be at BIO Europe Spring 2024. The countdown to BIO Europe Spring has begun, and we're thrilled to announce our participation again this year! Our Business Development Manager, Sofie Arpe, will be on ground in Barcelona – ready to discuss how Blueskin CRO can help accelerate your clinical dermatology research programs with high-quality protocol designing, fit-for-purpose site feasibility and patient assessments. Join us as we continue our mission to advance dermatological research. Reach out to Sofie Arpe at soa@sanos.com to arrange a meeting. See you there! #BIOEuropeSpring #ClinicalResearch #Dermatology #BlueskinCRO #partofSanosGroup